{
  "node_id": "us-orphan-drug-act-1983-section-526-designation",
  "title": "Orphan Drug Act of 1983, Section 526 - Designation of Orphan Drugs",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.1",
  "last_updated": "2026-04-30",
  "bluf": "The Orphan Drug Act of 1983, Section 526, requires the FDA to designate a drug as an orphan drug if it is intended for the treatment…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "industry_mapping"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "dependencies": [
    "fda-21-cfr-part-312-ind-investigational-new-drug"
  ],
  "primary_citations_count": 5,
  "workflow_steps_count": 6,
  "schema_fields_count": 6,
  "citation_preview": [
    "Orphan Drug Act of 1983, Section 526(a)(1) - Definition of Orphan Drug",
    "Orphan Drug Act of 1983, Section 526(a)(2) - Requirements for Orphan Drug Designation"
  ]
}